NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation.
about
The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivityNitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitroDisplacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart.Cholinergic control of heart rate by nitric oxide is site specific.Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channelsModulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.A common mechanism in the protective effects of preconditioning, cardiac pacing and physical exercise against ischemia and reperfusion-induced arrhythmias.Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice.Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.Neuronal control of heart rate in isolated mouse atria.Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node.A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep.The Effects of Passive Simulated Jogging on Short-Term Heart Rate Variability in a Heterogeneous Group of Human Subjects
P2860
Q28344843-A378195B-78EA-4EB3-B8CC-1A476643EC95Q28348784-ECBD4DFE-56E1-47C4-B3E8-6B80B98F06A1Q30423062-E6990812-7854-472B-81C2-EF9F9E5B29B9Q34882759-D6FC2894-0915-4097-B525-E39246977CA7Q35213988-59974B87-03D0-4438-ABEB-6E609EE58294Q37002383-71926D57-3C1A-4006-96ED-DA2BB9D10577Q37230807-CEB6FB80-BFB9-47B2-9A80-23CEBA387001Q38750251-560496AE-CFCA-46FD-967B-3FEA95BA1B83Q41823968-96369906-BA79-43F6-985E-C93685183426Q43799971-F32FC543-CE09-4B01-83C5-8105E6BF8294Q43799974-589AD762-1EBE-473D-BBF7-987C7647E5F4Q44435087-30613EB5-F70A-4C84-95D5-030C72C12EE3Q44525854-4EC8059D-CBC5-42CA-9F1D-E311BEE0C68DQ48187354-7C4EC7E8-6207-4513-B667-A2A70F492BD7Q58596201-F3B600DD-F8D1-4490-B563-3F37CCC9F8F8
P2860
NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@en
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@nl
type
label
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@en
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@nl
prefLabel
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@en
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@nl
P2093
P2860
P1476
NO-cGMP pathway accentuates th ...... rdiac vagal nerve stimulation.
@en
P2093
D J Paterson
J K Choate
P2860
P304
P356
10.1152/JAPPL.1999.86.2.510
P407
P577
1999-02-01T00:00:00Z